EUVIMEDEUVIMED entdecken
Open Access

Hepatitis B virus core protein stabilizes RANGAP1 to upregulate KDM2A and facilitate hepatocarcinogenesis

Hong-Juan You, Li-Hong Ma, Xing Wang, Yu-Xin Wang, Huan-Yang Zhang, En-Si Bao, Yu-Jie Zhong, Xiang-Ye Liu, De-Long Kong, Kui-Yang Zheng, Fan-Yun Kong, Ren-Xian Tang

Cellular Oncology · 2024-04 · 47 (2) · 639-655

DOI: 10.1007/s13402-023-00889-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 17.10.2023. Verfasst von Hong-Juan You und 11 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Hepatitis B virus, Up-Regulation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the Natural Science Foundation of Jiangsu Province, the Natural Science Foundation of the Jiangsu Higher Education Institutions, Xuzhou Technology Bureau Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: As a vital component of the hepatitis B virus (HBV) nucleocapsid, HBV core protein (HBC) contributes to hepatocarcinogenesis. Here, we aimed to assess the effects of RANGAP1 and KDM2A on tumorigenesis induced by HBC. METHODS: Co-immunoprecipitation (Co-IP) combined with mass spectrometry were utilized to identify the proteins with the capacity to interact with HBC. The gene and protein levels of RANGAP1 and KDM2A in hepatocellular carcinoma (HCC) and HBV-positive HCC tissues were evaluated using different cohorts. The roles of RANGAP1 and KDM2A in HCC cells mediated by HBC were investigated in vitro and in vivo. Co-IP and western blot were used to estimate the interaction of HBC with RANGAP1 and KDM2A and assess RANGAP1 stabilization regulated by HBC. RESULTS: We discovered that HBC could interact with RANGAP1 and KDM2A, the levels of which were markedly elevated in HCC tissues. Relying on RANGAP1 and KDM2A, HBC facilitated HCC cell growth and migration. The increased stabilization of RANGAP1 mediated by HBC was relevant to the disruption of the interaction between RANGAP1 and an E3 ligase SYVN1. RANGAP1 interacted with KDM2A, and it further promoted KDM2A stabilization by disturbing the interaction between KDM2A and SYVN1. HBC enhanced the interaction of KDM2A with RANGAP1 and upregulated the expression of KDM2A via RANGAP1 in HCC cells. CONCLUSIONS: These findings demonstrate a novel mechanism by which HBC facilitates hepatocarcinogenesis. RANGAP1 and KDM2A could act as potential molecular targets for treating HBV-associated malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularHepatitis B virusUp-RegulationJumonji Domain-Containing Histone DemethylasesHumansCell Line, TumorViral Core ProteinsAnimalsCarcinogenesisMice, NudeMaleCell ProliferationProtein StabilityGene Expression Regulation, NeoplasticFemaleCell MovementMiddle AgedF-Box Proteins

Stichwörter der Autor:innen

HBCHepatocellular carcinomaKDM2ARANGAP1SYVN1

Substanzen

KDM2A protein, humanJumonji Domain-Containing Histone DemethylasesViral Core ProteinsF-Box Proteins

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • National Demonstration Center for Experimental Basic Medical Sciences Education, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, China. kong.fanyun@163.com.
  • Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, China. tangrenxian-t@163.com.
  • National Demonstration Center for Experimental Basic Medical Sciences Education, Xuzhou Medical University, Xuzhou, Jiangsu, China. tangrenxian-t@163.com.

Förderung

  • the Natural Science Foundation of Jiangsu Province
  • the Natural Science Foundation of the Jiangsu Higher Education Institutions
  • Xuzhou Technology Bureau Foundation
  • a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions

Zitieren

APA

You, H. J., Ma, L. H., Wang, X., Wang, Y. X., Zhang, H. Y., Bao, E. S., Zhong, Y. J., Liu, X. Y., Kong, D. L., Zheng, K. Y., Kong, F. Y., & Tang, R. X. (2024). Hepatitis B virus core protein stabilizes RANGAP1 to upregulate KDM2A and facilitate hepatocarcinogenesis. Cellular Oncology, 47(2), 639-655. https://doi.org/10.1007/s13402-023-00889-4

Vancouver

You HJ, Ma LH, Wang X, Wang YX, Zhang HY, Bao ES, et al. Hepatitis B virus core protein stabilizes RANGAP1 to upregulate KDM2A and facilitate hepatocarcinogenesis. Cellular Oncology. 2024;47(2):639-655. doi:10.1007/s13402-023-00889-4

BibTeX
@article{You2024,
  author = {You, Hong-Juan and Ma, Li-Hong and Wang, Xing and Wang, Yu-Xin and Zhang, Huan-Yang and Bao, En-Si and Zhong, Yu-Jie and Liu, Xiang-Ye and Kong, De-Long and Zheng, Kui-Yang and Kong, Fan-Yun and Tang, Ren-Xian},
  title = {Hepatitis B virus core protein stabilizes RANGAP1 to upregulate KDM2A and facilitate hepatocarcinogenesis},
  journal = {Cellular Oncology},
  year = {2024},
  volume = {47},
  number = {2},
  pages = {639--655},
  doi = {10.1007/s13402-023-00889-4}
}
Kostenlos starten →